<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01578356</url>
  </required_header>
  <id_info>
    <org_study_id>2012/122</org_study_id>
    <nct_id>NCT01578356</nct_id>
  </id_info>
  <brief_title>Oncological and Functional Outcomes After Radical Prostatectomy for Prostate Cancer: Comparing Open With Robot-assisted Surgery</brief_title>
  <official_title>Oncological and Functional Outcomes After Radical Prostatectomy for Prostate Cancer: Comparing Open With Robot-assisted Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      For primary surgical treatment of prostate cancer the investigators compare the classic open
      surgery (radical retropubic prostatectomy, RRP) versus robot-assisted laparoscopic surgery
      (RALP). Oncological results are obtained at standard follow-up consultations through
      Prostate-Specific Antigen (PSA) measurement to detect biochemical recurrence. Functional
      results (continence, potency, quality of life) are obtained through standardised
      questionnaires. Currently the investigators perform all of their prostatectomies in a
      robot-assisted manner. For results of the open surgery the investigators send questionnaires
      to patients who had the operation in the past.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Biochemical recurrence at follow-up.</measure>
    <time_frame>3 months after prostatectomy</time_frame>
    <description>PSA measurement in the serum should not be &gt; or = 0,20 ng/ml.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biochemical recurrence at follow-up</measure>
    <time_frame>6 months after prostatectomy</time_frame>
    <description>PSA measurement in the serum should not be &gt; or = 0,20 ng/ml.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biochemical recurrence at follow-up.</measure>
    <time_frame>9 months after prostatectomy</time_frame>
    <description>PSA measurement in the serum should not be &gt; or = 0,20 ng/ml.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biochemical recurrence at follow-up.</measure>
    <time_frame>1 year after prostatectomy</time_frame>
    <description>PSA measurement in the serum should not be &gt; or = 0,20 ng/ml.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biochemical recurrence at follow-up.</measure>
    <time_frame>6-monthly follow up between 1 and 5 years after prostatectomy.</time_frame>
    <description>PSA measurement in the serum should not be &gt; or = 0,20 ng/ml.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional assessment concerning continence.</measure>
    <time_frame>after 1, 3, 12 and 24 months</time_frame>
    <description>Patients need to fill out questionnaires (EORTC QLQ-C30, QLQ-PR25, ICIQ mLUTS and UI SF and IIEF). The patients in the radical retropubic prostatectomy group only fill out the questionnaires once.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional assessment concerning potency.</measure>
    <time_frame>after 1, 3, 12 and 24 months</time_frame>
    <description>Patients need to fill out questionnaires (EORTC QLQ-C30, QLQ-PR25, ICIQ mLUTS and UI SF and IIEF). The patients in the radical retropubic prostatectomy group only fill out the questionnaires once.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional assessment concerning quality of life.</measure>
    <time_frame>after 1, 3, 12 and 24 months</time_frame>
    <description>Patients need to fill out questionnaires (EORTC QLQ-C30, QLQ-PR25, ICIQ mLUTS and UI SF and IIEF). The patients in the radical retropubic prostatectomy group only fill out the questionnaires once.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Radical Retropubic prostatectomy (RRP)</arm_group_label>
    <description>Men who underwent open radical prostatectomy in the past at our centre.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Robot-assisted laparoscopic prostatectomy (RALP)</arm_group_label>
    <description>Men who undergo robot-assisted laparoscopic prostatectomy at our centre.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Men who were surgically treated or who are being surgically treated for prostate cancer.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  prostate cancer

          -  radical retropubic prostatectomy or

          -  robot-assisted laparoscopic surgery

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolaas Lumen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicolaas Lumen, MD</last_name>
    <email>Nicolaas.Lumen@uzgent.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ghent University Hospital</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolaas Lumen, MD</last_name>
      <email>Nicolaas.Lumen@uzgent.be</email>
    </contact>
    <investigator>
      <last_name>Nicolaas Lumen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://www.uzgent.be</url>
  </link>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2012</study_first_submitted>
  <study_first_submitted_qc>April 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2012</study_first_posted>
  <last_update_submitted>December 4, 2014</last_update_submitted>
  <last_update_submitted_qc>December 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prostate cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

